Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Brian J Parks"'
Autor:
Venumadhav Janganati, Paloma Salazar, Brian J. Parks, Gregory S. Gorman, Paul L. Prather, Eric C. Peterson, Alexander W. Alund, Jeffery H. Moran, Peter A. Crooks, Lisa K. Brents
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: An active metabolite of buprenorphine (BUP), called norbuprenorphine (NorBUP), is implicated in neonatal opioid withdrawal syndrome when BUP is taken during pregnancy. Therefore, reducing or eliminating metabolism of BUP to NorBUP is a
Externí odkaz:
https://doaj.org/article/851ee0a95e754823870b37ba2b585594
Autor:
Julia Tobacyk, Brian J. Parks, Lori Coward, Michael D. Berquist, Gregory S. Gorman, Lisa K. Brents
Publikováno v:
Journal of Clinical and Translational Science, Vol 7, Pp 139-140 (2023)
OBJECTIVES/GOALS: Buprenorphine (BUP) is used for opioid use disorder during pregnancy but causes neonatal opioid withdrawal syndrome (NOWS). The goal of this study was to determine the contribution of the active metabolite, norbuprenorphine (NorBUP)
Externí odkaz:
https://doaj.org/article/5d3dca4f3b85413fb384145a37f29147
Autor:
Julia Tobacyk, Brian J Parks, Paloma Salazar, Lori Coward, Michael D Berquist, Gregory S Gorman, Lisa K Brents
Buprenorphine (BUP) is the preferred treatment for opioid use disorder during pregnancy but can cause neonatal opioid withdrawal syndrome (NOWS). Norbuprenorphine (NorBUP), an active metabolite of BUP, is implicated in BUP-associated NOWS. We hypothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ef91f7126cff0d1aa2f57ca0debb95f
https://doi.org/10.1101/2022.12.27.521115
https://doi.org/10.1101/2022.12.27.521115
Autor:
Brian J. Parks, Paloma Salazar, Julia Tobacyk, Lindsey L. Morrison, Michael D. Berquist, Lisa K. Brents
Publikováno v:
The FASEB Journal. 36
Publikováno v:
The International journal on drug policy. 108
The legal status of kratom in the United States is complex and varies by state. The U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration have repeatedly subjected kratom to regulatory review. However, there hasn't been
Mycobacterium abscessus(Mab) is a biofilm-forming, multi-drug resistant, non-tuberculous mycobacterial (NTM) pathogen increasingly found in Cystic Fibrosis patients. Antibiotic treatment for these infections is often unsuccessful, partly due toMab’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7f18f8241380d2450dcfd456a76e44
https://doi.org/10.1101/479923
https://doi.org/10.1101/479923
Publikováno v:
Antimicrobial agents and chemotherapy. 63(7)
Mycobacterium abscessus is a biofilm-forming, multidrug-resistant nontuberculous mycobacterial (NTM) pathogen increasingly found in cystic fibrosis patients. Antibiotic treatment for these infections is often unsuccessful, partly due to M. abscessus'